Pfizer CentreOne Launches Bold New Development Services Campaign

Pfizer CentreOne, the global pharmaceutical contract development and manufacturing organization (CDMO) embedded within Pfizer, has launched a bold new campaign for its development services offer with the theme of ‘Experience the Art of Science’.

The campaign focuses on the creative thinking and novel approaches that go into Pfizer CentreOne’s development services work, which is represented visually using macro shots of real scientific images altered to look like abstract art.

‘Experience the Art of Science’ seeks to highlight the breadth of expertise and technology behind Pfizer CentreOne’s drug development and optimization services. The CDMO's services cover formulation, clinical drug manufacturing, analytical testing, validation and method development for small molecule APIs, large molecule biologics, oral solids and sterile injectables.

Christine Loria, Global Customer Acquisition Marketing Lead said: “This campaign has been inspired by hearing how Pfizer CentreOne has helped customers by addressing complex scientific challenges in an innovative way on their project. We’ve used actual science-based images from Pfizer colleagues to go beyond typical visuals and highlight the great work of our teams in a unique way.

We’re excited to tell the market about this offering. We’re seeing an increased demand for development services, particularly from small to medium biotechs and we look forward to collaborating with them to deliver breakthroughs for patients. -- Nicole Strauss, Pipeline Development and Innovation Lead

The campaign will launch officially in early December 2020 across LinkedIn and trade media channels. Find out more here.